1-3 of 3
Joi Dunbar, PharmD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

a Phase 1 Evaluation of Duvelisib (IPI-145), a PI3K-δ,γ Inhibitor, in Patients with Relapsed/Refractory iNHL

Ian Flinn, Yasuhiro Oki, MD, Manish Patel, Steven M. Horwitz, MD, Francine M. Foss, MD, Jennifer Sweeney, Kerstin Allen, MA, Mark Douglas, MS, Lori Steelman, Joi Dunbar, PharmD, Howard M. Stern, MD PhD, Patrick Kelly, MD, Brad Kahl, MD
Journal: Blood
Blood (2014) 124 (21): 802.
https://doi.org/10.1182/blood.V124.21.802.802
Published: 2014
Journal Articles

Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia

Ian Flinn, MD, PhD, Manish Patel, MD, Brad S. Kahl, MD, Steven M. Horwitz, MD, Francine M. Foss, MD, Yasuhiro Oki, MD, Pierluigi Porcu, MD, Jennifer Sweeney, BS, Kerstin Allen, MA, Kerrie Faia, MS, Patricia Harris, MPH, Joi Dunbar, PharmD, Howard M. Stern, M.D., Ph.D., Patrick Kelly, MD, Susan O'Brien, MD
Journal: Blood
Blood (2013) 122 (21): 677.
https://doi.org/10.1182/blood.V122.21.677.677
Published: 2013
Journal Articles

Pharmacokinetics and Pharmacodynamics of IPI-145, a Potent Inhibitor of Phosphoinositide-3-Kinase-δ,γ, Following Single- and Multiple-Dose Administration in Healthy Subjects and Patients with Advanced Hematologic Malignancies

Joi Dunbar, PharmD, Jylle Nevejans, Charlotte McKee, MD, Kerrie Faia, MS, Jan Jaap van Lier, MD, Peter Pruim, MSc, Janet Stegehuis, PhD, Sue Zhao, MS, Brad S. Kahl, M.D., Steven M. Horwitz, MD, Manish Patel, MD, Anas Younes, MD, Ian W. Flinn, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4853.
https://doi.org/10.1182/blood.V120.21.4853.4853
Published: 2012